Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOVNYSE:HIMS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.60-2.4%$3.83$0.61▼$4.87$1.84B1.986.77 million shs3.94 million shsHIMSHims & Hers Health$27.24+1.1%$37.59$11.20▼$72.98$6.05B1.6515.29 million shs18.47 million shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments-2.44%-1.91%-5.51%-11.76%+479.06%HIMSHims & Hers Health+1.19%+1.70%-13.40%-2.02%+120.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLOVClover Health Investments3.1916 of 5 stars3.35.00.00.02.92.50.6HIMSHims & Hers Health3.5874 of 5 stars4.12.00.00.02.03.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.67Moderate Buy$4.8334.26% UpsideHIMSHims & Hers Health 2.21Hold$38.2540.41% UpsideCurrent Analyst Ratings BreakdownLatest CLOV and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/10/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$39.00 ➝ $33.004/2/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell3/18/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$21.00 ➝ $22.003/6/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.003/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$27.00 ➝ $27.003/3/2025CLOVClover Health InvestmentsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$4.20 ➝ $4.502/26/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$24.00 ➝ $39.002/25/2025HIMSHims & Hers HealthLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $40.002/25/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$24.00 ➝ $35.002/25/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$25.00 ➝ $27.002/25/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$31.00 ➝ $61.00(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.37B1.34N/AN/A$0.59 per share6.10HIMSHims & Hers Health$1.48B4.10N/AN/A$1.61 per share16.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$213.36M-$0.09N/AN/AN/A-5.92%-25.46%-12.35%5/6/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.5461.9152.39N/A8.19%10.97%8.29%5/5/2025 (Estimated)Latest CLOV and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025CLOVClover Health Investments-$0.07N/AN/AN/A$466.93 millionN/A5/5/2025Q1 2025HIMSHims & Hers Health$0.11N/AN/AN/A$535.21 millionN/A2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.551.55HIMSHims & Hers HealthN/A2.141.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%HIMSHims & Hers Health63.52%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments22.28%HIMSHims & Hers Health17.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680510.91 million389.46 millionOptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableCLOV and HIMS HeadlinesRecent News About These CompaniesHims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth KnowingApril 17 at 6:50 PM | zacks.comHIMS Stock: Time For A Turnaround?April 17 at 6:21 PM | sohu.com3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff WoesApril 17 at 10:55 AM | zacks.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 3,236 SharesApril 17 at 5:31 AM | insidertrades.comWhy Hims & Hers Health, Inc. (HIMS) Declined on WednesdayApril 17 at 12:48 AM | insidermonkey.comIs HIMS Stock Ready For A Rebound After A 60% Fall?April 16 at 5:41 PM | forbes.comRobinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To KnowApril 16 at 5:41 PM | msn.comHims & Hers Health, Inc. (HIMS): A Bull Case TheoryApril 16 at 4:18 PM | insidermonkey.comHims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play itApril 16 at 9:45 AM | zacks.comFederated Hermes Inc. Has $4.38 Million Position in Hims & Hers Health, Inc. (NYSE:HIMS)April 15 at 4:48 AM | marketbeat.comHims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025April 14, 2025 | gurufocus.comQuinn Opportunity Partners LLC Sells 690,682 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)April 14, 2025 | marketbeat.com22,739 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Purchased by Aviva PLCApril 14, 2025 | marketbeat.comTruist Financial Issues Pessimistic Forecast for Hims & Hers Health (NYSE:HIMS) Stock PriceApril 12, 2025 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Geode Capital Management LLCApril 12, 2025 | marketbeat.comTruist Financial Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock PriceApril 12, 2025 | americanbankingnews.comHims & Hers price target raised to $25 from $21 at JefferiesApril 11, 2025 | markets.businessinsider.comHims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should KnowApril 11, 2025 | zacks.comAbacus FCF Advisors LLC Invests $608,000 in Hims & Hers Health, Inc. (NYSE:HIMS)April 11, 2025 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 33,337 SharesApril 11, 2025 | insidertrades.comFranklin Resources Inc. Sells 735,863 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)April 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Are Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military Spending3 Stocks Near 52-Week Lows With Strong Rebound PotentialBy Gabriel Osorio-Mazilli | March 31, 2025View 3 Stocks Near 52-Week Lows With Strong Rebound PotentialHims’ Weight Loss Expansion: Real Growth or Just Hype?By Leo Miller | April 10, 2025View Hims’ Weight Loss Expansion: Real Growth or Just Hype?CLOV and HIMS Company DescriptionsClover Health Investments NASDAQ:CLOV$3.60 -0.09 (-2.44%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.62 +0.02 (+0.69%) As of 04/17/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Hims & Hers Health NYSE:HIMS$27.24 +0.29 (+1.08%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$27.34 +0.09 (+0.35%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk Tariff-Resistant Abbott Laboratories on Track for New Highs Goldman Sachs Just Revealed What’s Next for Markets United Airlines Is in Reversal—If the Economy Doesn’t Stall Buy the Boeing Dip Even on Tariff and Bans? Spotify Stock Climbs as Its Growth Strategy Diversifies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
